Key terms

About VSTM

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest VSTM news

Apr 16 6:00am ET Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), Laboratory (LH) and Longboard Pharmaceuticals (LBPH) Apr 12 7:00am ET Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Verastem (VSTM) Apr 09 5:22pm ET Verastem Releases Updated Corporate Presentation for Investors Apr 04 7:31am ET Verastem announces inducement grants under Nasdaq listing rule Mar 19 6:18am ET Verastem: Financial Resilience and Promising Drug Pipeline Despite Short-Term Losses Mar 16 12:30pm ET Analysts’ Top Healthcare Picks: Verastem (VSTM), Akebia Therapeutics (AKBA) Mar 16 2:02am ET Verastem Inc. at a Crossroads: Navigating the Perilous Terrain of Patent Ownership and IP Rights Mar 14 4:26pm ET Verastem reports Q4 adjusted EPS ($1.10), consensus (62c) Mar 11 1:10am ET Analysts Are Bullish on These Healthcare Stocks: Wave Life Sciences (WVE), Dexcom (DXCM) Mar 05 5:29pm ET Verastem receives Orphan Drug Designation from FDA for avutometinib Mar 05 8:53am ET Verastem treatment of low grade serous ovarian cancer granted orphan designation Jan 29 8:46pm ET Buy Rating on Verastem: Strategic Execution and Promising Drug Pipeline Signal Market Opportunity Jan 20 3:06am ET Verastem Shareholders Approve Executive Option Exchange Plan Jan 18 4:02pm ET Verastem granted fast track designation for Avutometinib+Sotorasib in NSCLC

No recent press releases are available for VSTM

VSTM Financials

1-year income & revenue

Key terms

VSTM Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

VSTM Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms